CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) (Unaudited) - USD ($)	Convertible Series A Preferred Stock Preferred Stock	Convertible Series B-1A Preferred Stock Preferred Stock	Convertible Series B-1 Preferred Stock Preferred Stock	Convertible Series B-2 Preferred Stock Preferred Stock	Preferred Stock	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Total
Retroactive application of reverse recapitalization	$ (1,000)	$ (317)	$ (1,050)			$ 30,563	$ (20,651)		$ 7,545
Retroactive application of reverse recapitalization (in shares)	(1,000,000)	(316,848)	(1,050,695)			30,563,009
Balance (as previously reported) at Dec. 31, 2019	$ 1,000	$ 317	$ 1,050	$ 0		$ 10,686	33,538,813	$ (38,402,816)	(4,850,950)
Balance (as previously reported) (in shares) at Dec. 31, 2019	1,000,000	316,848	1,050,695	0		10,686,191
Beginning balance at Dec. 31, 2019						$ 41,249	33,518,162	(38,402,816)	(4,843,405)
Beginning balance (in shares) at Dec. 31, 2019						41,249,200
Common stock issued						$ 51	176,974		177,025
Common stock issued (in shares)						50,844
Series B-2 convertible preferred stock issued						$ 13	50,000		50,013
Series B-2 convertible preferred stock issued (in shares)						13,168
Stock-based compensation							88,803		88,803
Net income (loss)								(1,590,056)	(1,590,056)
Ending balance at Mar. 31, 2020						$ 41,313	33,833,939	(39,992,872)	(6,117,620)
Ending balance (in shares) at Mar. 31, 2020						41,313,212
Balance (as previously reported) at Dec. 31, 2019	$ 1,000	$ 317	$ 1,050	$ 0		$ 10,686	33,538,813	(38,402,816)	(4,850,950)
Balance (as previously reported) (in shares) at Dec. 31, 2019	1,000,000	316,848	1,050,695	0		10,686,191
Beginning balance at Dec. 31, 2019						$ 41,249	33,518,162	(38,402,816)	$ (4,843,405)
Beginning balance (in shares) at Dec. 31, 2019						41,249,200
Common stock issued to settle note conversion (in shares)									1,138,199
Net income (loss)									$ (6,649,481)
Ending balance at Sep. 30, 2020						$ 42,744	42,180,599	(45,052,297)	(2,828,954)
Ending balance (in shares) at Sep. 30, 2020						42,743,945
Beginning balance at Mar. 31, 2020						$ 41,313	33,833,939	(39,992,872)	(6,117,620)
Beginning balance (in shares) at Mar. 31, 2020						41,313,212
Stock-based compensation							93,466		93,466
Net income (loss)								102,287	102,287
Ending balance at Jun. 30, 2020						$ 41,313	33,927,405	(39,890,585)	(5,921,867)
Ending balance (in shares) at Jun. 30, 2020						41,313,212
Common stock issued						$ 293	1,411,774		1,412,067
Common stock issued (in shares)						292,534
Common stock issued to settle note conversion						$ 1,138	3,960,988		3,962,126
Common stock issued to settle note conversion (in shares)						1,138,199
Warrants issued as compensation for services							2,689,684		2,689,684
Stock-based compensation							190,749		190,749
Net income (loss)								(5,161,712)	(5,161,712)
Ending balance at Sep. 30, 2020						$ 42,744	42,180,599	(45,052,297)	(2,828,954)
Ending balance (in shares) at Sep. 30, 2020						42,743,945
Retroactive application of reverse recapitalization	$ (1,000)	$ (317)	$ (1,050)	$ (4)		$ 31,746	(21,786)		7,589
Retroactive application of reverse recapitalization (in shares)	(1,000,000)	(316,848)	(1,050,695)		(4,167)	31,745,786
Balance (as previously reported) at Dec. 31, 2020	$ 1,000	$ 317	$ 1,050	4		$ 11,228	46,387,649	(90,179,720)	(43,778,472)
Balance (as previously reported) (in shares) at Dec. 31, 2020	1,000,000	316,848	1,050,695		4,167	11,227,676
Beginning balance at Dec. 31, 2020						$ 42,974	46,365,863	(90,179,720)	(43,770,883)
Beginning balance (in shares) at Dec. 31, 2020						42,973,462
Common stock issued						$ 333	6,926,753		6,927,086
Common stock issued (in shares)						333,121
Proceeds from issuance of common stock for exercise of warrant						$ 1,496	7,498,522		7,500,018
Proceeds from issuance of common stock for exercise of warrant (in shares)						1,496,216
Reclassification of settlement liability upon issuance of warrant							60,851,779		60,851,779
Stock-based compensation							371,698		371,698
Net income (loss)								(25,488,874)	(25,488,874)
Ending balance at Mar. 31, 2021						$ 44,803	122,014,615	(115,668,594)	6,390,824
Ending balance (in shares) at Mar. 31, 2021						44,802,799
Balance (as previously reported) at Dec. 31, 2020	$ 1,000	$ 317	$ 1,050	$ 4		$ 11,228	46,387,649	(90,179,720)	(43,778,472)
Balance (as previously reported) (in shares) at Dec. 31, 2020	1,000,000	316,848	1,050,695		4,167	11,227,676
Beginning balance at Dec. 31, 2020						$ 42,974	46,365,863	(90,179,720)	(43,770,883)
Beginning balance (in shares) at Dec. 31, 2020						42,973,462
Effect of Merger and recapitalization, net of redemptions and issuance costs									(64,836,244)
Issuance of common stock for exercise of warrants and Unit Purchase Options									$ 47,319,504
Common stock issued for consulting services (in shares)									834,045
Net income (loss)									$ (62,655,819)
Ending balance at Sep. 30, 2021						$ 54,810	161,261,845	(152,835,538)	8,481,117
Ending balance (in shares) at Sep. 30, 2021						54,810,338
Beginning balance at Mar. 31, 2021						$ 44,803	122,014,615	(115,668,594)	6,390,824
Beginning balance (in shares) at Mar. 31, 2021						44,802,799
Common stock issued						$ 71	1,562,201		1,562,272
Common stock issued (in shares)						71,056
Effect of Merger and recapitalization, net of redemptions and issuance costs						$ 2,530	(64,838,774)		(64,836,244)
Effect of Merger and recapitalization, net of redemptions and issuance costs (in shares)						2,529,730
Common stock issued pursuant to PIPE financing, net of issuance costs						$ 1,000	8,099,000		8,100,000
Common stock issued pursuant to PIPE financing, net of issuance costs (in shares)						1,000,000
Common stock issued for advisor services						$ 200	4,849,800		4,850,000
Common stock issued for advisor services (in shares)						200,000
Modification of option awards pursuant to Merger							1,014,640		1,014,640
Modification of warrants pursuant to Merger							2,330,572		2,330,572
Stock-based compensation							938,118		938,118
Net income (loss)								(117,613)	(117,613)
Ending balance at Jun. 30, 2021						$ 48,604	75,970,172	(115,786,207)	(39,767,431)
Ending balance (in shares) at Jun. 30, 2021						48,603,585
Common stock issued						$ 511	1,134,305		$ 1,134,816
Common stock issued (in shares)						511,065			511,065
Common stock and warrants issued in private placement, net of issuance costs						$ (2,727)	(27,355,496)		$ (27,358,223)
Common stock and warrants issued in private placement, net of issuance costs (in shares)						2,727,273
Issuance of common stock for exercise of warrants and Unit Purchase Options						$ 2,334	47,317,170		47,319,504
Issuance of common stock for exercise of warrants and Unit Purchase Options (in shares)						2,334,370
Common stock issued for consulting services						$ 634	7,924,877		$ 7,925,511
Common stock issued for consulting services (in shares)						634,045			634,045
Stock-based compensation							1,559,825		$ 1,559,825
Net income (loss)								(37,049,331)	(37,049,331)
Ending balance at Sep. 30, 2021						$ 54,810	$ 161,261,845	$ (152,835,538)	$ 8,481,117
Ending balance (in shares) at Sep. 30, 2021						54,810,338